FDA Adverse Event Injury Summary report: N

TI LOCKING SCREW

MDR report key: 12160217 · Received July 13, 2021

Report

Report Number
2939274-2021-03899
Event Type
Injury
Date Received
July 13, 2021
Report Date
June 14, 2021
Manufacturer
WRIGHTS LANE SYNTHES USA PRODUCTS LLC
Product Code
MNI
UDI-DI
10705034739229
PMA / PMN Number
K142838
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL PRODUCT CODES: KWP, MNH, NKG. INITIAL REPORTER IS A SYNTHES EMPLOYEE. WITHOUT A LOT NUMBER THE DEVICE HISTORY RECORDS REVIEW COULD NOT BE COMPLETED. PRODUCT WAS NOT RETURNED. BASED ON THE INFORMATION AVAILABLE, IT HAS BEEN DETERMINED THAT NO CORRECTIVE AND/OR PREVENTATIVE ACTION IS PROPOSED. THIS COMPLAINT WILL BE ACCOUNTED FOR AND MONITORED VIA POST MARKET SURVEILLANCE ACTIVITIES. IF ADDITIONAL INFORMATION IS MADE AVAILABLE, THE INVESTIGATION WILL BE UPDATED AS APPLICABLE. DEVICE WAS USED FOR TREATMENT, NOT DIAGNOSIS. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Description of Event or Problem · 0

THIS REPORT IS BEING FILED AFTER THE REVIEW OF A CLINICAL EVALUATION REPORT (CER) FROM A RELATED RESEARCH ACTIVITY DATABASE (DDRA) FOR PATIENTS UNDERGOING CERVICAL FUSION. THIS REPORT CAPTURES THE FOLLOWING COMPLICATIONS: PSEUDARTHROSIS AFTER FUSION OR ARTHRODESIS (5): PATIENT NO (B)(6), FEMALE, (B)(6) WHO UNDERWENT REVISION POSTERIOR CERVICAL FUSION WAS READMITTED DUE TO PSEUDARTHROSIS AFTER FUSION OR ARTHRODESIS. THIS REPORT IS FOR A POSTERIOR CERVICAL SYSTEMS (SYNAPSE) LOCKING SCREW. THIS IS REPORT 8 OF 8 FOR (B)(4). ADDITIONAL COMPLICATIONS FOR THIS CER ARE CAPTURED ON RELATED COMPLAINTS (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1056918 TI LOCKING SCREW ORTHOSIS, SPINAL PEDICLE FIXATION MNI WRIGHTS LANE SYNTHES USA PRODUCTS LLC 04.614.508 10705034739229

Patients

Seq Age Sex Outcome Treatment
1 62 YR Required Intervention